Omnicell logo
OMCLOmnicell
Trade OMCL now
Omnicell primary media

About Omnicell

Omnicell (NASDAQ:OMCL) specializes in medication and supply management solutions, offering a wide range of products and services aimed at improving healthcare efficiency and patient care. This company focuses on developing innovative pharmacy automation, analytics, and medication adherence solutions, helping healthcare facilities manage and optimize their medication dispensing and supply chain processes. With a strong commitment to technology and innovation, Omnicell's projects aim to reduce errors, enhance efficiency, and promote safety within the healthcare industry. Their objectives are centered on transforming the pharmacy care delivery model, ensuring that healthcare providers have the tools and data necessary to offer the best possible care to their patients.

What is OMCL known for?

Snapshot

Public US
Ownership
1992
Year founded
3357
Employees
Mountain View, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Products and/or services of Omnicell

  • Automated medication dispensing systems to enhance efficiency and safety in healthcare settings.
  • Central pharmacy robotic systems for accurate and timely medication distribution.
  • Point-of-care automation solutions for secure medication management at bedside.
  • IV compounding systems and robotics ensuring precise and safe preparation of intravenous medications.
  • Pharmacy analytics tools for data-driven decisions in hospital and retail pharmacies.
  • Cloud-based software platforms for comprehensive pharmacy management and interconnectivity.

Omnicell executive team

  • Mr. Randall A. LippsFounder, Executive Chairman, President & CEO
  • Mr. Nnamdi N. NjokuExecutive VP & COO
  • Mr. Corey J. ManleyExecutive VP, Chief Legal & Administrative Officer and Corporate Secretary
  • Mr. H. Baird Radford IIIExecutive VP & CFO
  • Mr. Brian H. NuttVP, Chief Accounting Officer & Corporate Controller
  • Dr. Perry A. Genova Ph.D.Senior VP & CTO
  • Ms. Kathleen NemethSenior Vice President of Investor Relations
  • Mr. Tomer StavitskySenior VP & Chief Corporate Development Officer
  • Ms. Stella PrefachSenior VP & Chief Marketing Officer
  • Mr. Dave FordSVP & Chief People Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.